Mirbeg 50 Tablet ER
Marketer
Ipca Laboratories Ltd
Salt Composition
Mirabegron (50mg)
Overview Mirbeg 50 Tablet ER
Extended-release Mirbeg 50mg tablets manage overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always follow your doctor's prescribed dosage and duration; it can be taken with or without food. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects immediately. Before starting treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require close monitoring and regular check-ups as directed by their physician.
Uses of Mirbeg 50 Tablet ER
Managing overactive bladder (OAB) symptoms
Major Benefits of Mirbeg 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mirbeg 50 ER Tablets. Ingest the tablet whole; avoid crushing, chewing, or breaking it. While Mirbeg 50 ER Tablets can be administered with or without food, consistent timing is recommended for optimal results.
Common Side effects of Mirbeg 50 Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Mirbeg 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mirbeg 50 ER Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Mirbeg 50 ER Tablets can be taken with or without food, consistency in timing is recommended.
How Mirbeg 50 Tablet ER works:
Mirbeg 50 Extended-Release tablets contain a beta-3 adrenergic agonist. This medication's action involves stimulating bladder receptors, resulting in bladder muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Mirbeg 50 Tablet ER with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mirbeg 50mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the risks and benefits prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mirbeg 50mg tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mirbeg 50 ER tablets.
KidneyCAUTION
Extended-release Mirbeg 50mg tablets require careful administration in individuals with advanced kidney impairment. Dosage modification for Mirbeg 50mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Mirbeg 50 Extended-Release tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Mirbeg 50 Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Mirbeg 50 Tablet ER :
Should you forget to take a Mirbeg 50 Tablet ER, ingest it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Mirbeg 50 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
| Actions | Selective beta-3 agonist for bladder control |
3,018 People bought this recently